Details for New Drug Application (NDA): 021644
✉ Email this page to a colleague
The generic ingredient in CLOBEX is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 021644
Tradename: | CLOBEX |
Applicant: | Galderma Labs |
Ingredient: | clobetasol propionate |
Patents: | 0 |
Pharmacology for NDA: 021644
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 021644
Suppliers and Packaging for NDA: 021644
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLOBEX | clobetasol propionate | SHAMPOO;TOPICAL | 021644 | NDA | Galderma Laboratories, L.P. | 0299-3847 | 0299-3847-00 | 1 BOTTLE in 1 BLISTER PACK (0299-3847-00) / 15 mL in 1 BOTTLE (0299-3847-05) |
CLOBEX | clobetasol propionate | SHAMPOO;TOPICAL | 021644 | NDA | Galderma Laboratories, L.P. | 0299-3847 | 0299-3847-04 | 1 BOTTLE in 1 CARTON (0299-3847-04) / 118 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SHAMPOO;TOPICAL | Strength | 0.05% | ||||
Approval Date: | Feb 5, 2004 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 021644
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Galderma Labs | CLOBEX | clobetasol propionate | SHAMPOO;TOPICAL | 021644-001 | Feb 5, 2004 | 7,316,810 | ⤷ Subscribe |
Galderma Labs | CLOBEX | clobetasol propionate | SHAMPOO;TOPICAL | 021644-001 | Feb 5, 2004 | 8,066,976 | ⤷ Subscribe |
Galderma Labs | CLOBEX | clobetasol propionate | SHAMPOO;TOPICAL | 021644-001 | Feb 5, 2004 | 8,066,975 | ⤷ Subscribe |
Galderma Labs | CLOBEX | clobetasol propionate | SHAMPOO;TOPICAL | 021644-001 | Feb 5, 2004 | 7,700,081 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription